113 related articles for article (PubMed ID: 37141638)
1. Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis.
Wu F; He J; Deng Q; Chen J; Peng M; Xiao J; Zeng Y; Yi L; Li Z; Tian R; Jiang Z
Biochem Biophys Res Commun; 2023 Jul; 664():108-116. PubMed ID: 37141638
[TBL] [Abstract][Full Text] [Related]
2. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway.
Zhou S; Wang Z; Zhao D; Fu Y; Zhang S; Wang Z; Zou X
World J Surg Oncol; 2024 May; 22(1):133. PubMed ID: 38762741
[TBL] [Abstract][Full Text] [Related]
3. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
4. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
[TBL] [Abstract][Full Text] [Related]
5. Neuroglobin promotes the proliferation and suppresses the apoptosis of glioma cells by activating the PI3K/AKT pathway.
Zhang B; Liu Y; Li Y; Zhe X; Zhang S; Zhang L
Mol Med Rep; 2018 Feb; 17(2):2757-2763. PubMed ID: 29207186
[TBL] [Abstract][Full Text] [Related]
6. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
7. Loss of Neuroglobin Expression Alters Cdkn1a/Cdk6-Expression Resulting in Increased Proliferation of Neural Stem Cells.
Luyckx E; Van Leuven W; Andre D; Quarta A; Reekmans K; Fransen E; Moens L; Hankeln T; Ponsaerts P; Dewilde S
Stem Cells Dev; 2018 Mar; 27(6):378-390. PubMed ID: 29357734
[TBL] [Abstract][Full Text] [Related]
8. Neuroglobin plays as tumor suppressor by disrupting the stability of GPR35 in colorectal cancer.
Xiang Q; Zhou D; Xiang X; Le X; Deng C; Sun R; Li C; Pang H; He J; Zheng Z; Tang J; Peng W; Peng X; He X; Wu F; Qiu J; Xu Y; Xiang T
Clin Epigenetics; 2023 Apr; 15(1):57. PubMed ID: 37005662
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
Kimple RJ; Vaseva AV; Cox AD; Baerman KM; Calvo BF; Tepper JE; Shields JM; Sartor CI
Clin Cancer Res; 2010 Feb; 16(3):912-23. PubMed ID: 20103665
[TBL] [Abstract][Full Text] [Related]
10. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.
Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S
Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858
[TBL] [Abstract][Full Text] [Related]
11. Saikosaponin-A Exhibits Antipancreatic Cancer Activity by Targeting the EGFR/PI3K/Akt Pathway.
Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q
Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139
[TBL] [Abstract][Full Text] [Related]
12. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the 17β-estradiol pathways necessary for neuroglobin anti-apoptotic activity in breast cancer.
Fiocchetti M; Cipolletti M; Ascenzi P; Marino M
J Cell Physiol; 2018 Jul; 233(7):5087-5103. PubMed ID: 29219195
[TBL] [Abstract][Full Text] [Related]
14. Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis.
Zhang B; Chang M; Wang J; Liu Y
Biomed Pharmacother; 2017 Apr; 88():173-180. PubMed ID: 28103511
[TBL] [Abstract][Full Text] [Related]
15. The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway.
Tan B; Huang Y; Zhang B; Lin N
Biomed Pharmacother; 2020 Aug; 128():110133. PubMed ID: 32447207
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway.
Cipolletti M; Montalesi E; Nuzzo MT; Fiocchetti M; Ascenzi P; Marino M
J Cell Physiol; 2019 Apr; 234(4):3147-3157. PubMed ID: 30421506
[TBL] [Abstract][Full Text] [Related]
18. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
19. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
20. DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis.
Chen L; Niu W; Zang H; Qiu Y
Biochem Genet; 2024 Apr; 62(2):814-830. PubMed ID: 37460862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
